Last reviewed · How we verify
NCT04843748
Clinical Evaluation Study for Assessing the Visual Performance of Hanita Lenses Trifocal IOL
NA trial testing cataract surgery and intraocular lens implantation - both eyes in Cataract in 20 participants. Completed in 6 January 2021.
6 January 2021
Quick facts
| Lead sponsor | Hanita Lenses |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 18 August 2018 |
| Primary completion | 6 January 2021 |
| Estimated completion | 6 January 2021 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- cataract surgery and intraocular lens implantation - both eyes
Conditions studied
- Cataract — all drugs for Cataract →
Sponsor
Hanita Lenses
Who can join
Adults 45 to 75, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hanita Lenses Trifocal IOL, SeeLens AFR (Intensity IOL).Prospective, single-arm single-center, open-label study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04843748
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Hanita Lenses trials
Trials by the same sponsor.
- NCT06084169 — Investigation for Assessing the Visual Performance of Hanita Lenses Intensity SL IOL in Comparison to Alcon Panoptix IOL · NA · unknown
- NCT06220331 — Data Collection After Intensity IOL Implantations · completed
- NCT06083025 — Influence of CleaRing Open-capsule Device on Refractive Predictability in Cataract Patients (Part 2) · NA · unknown
- NCT06075459 — Post Marketing Clinical Evaluation Assessing the Visual Performance of Hanita Lenses "Intensity SL" Intraocular Lens · completed
- NCT05504343 — Assessing The Visual Performance Of Hanita Lenses "Intensity SL" Intraocular Lens · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04843748 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hanita Lenses
- Last refreshed: 14 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04843748.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing